Saif Al-Shamarti
Vol. 8, Jul-Dec 2019
Abstract:
Studyaimwas to determinepatient’s ocular complications in following injection of intravitrealLucentis(Ranibizumab) with retinopathy proliferative diabetic.InDr. Saif eye center,the study was performed. One hundred and twenty patients were participatedof age ranging from 30-70 years. After injection,eight patientswith sub-conjunctival hemorrhagewerespontaneously resolved within a week. Five patients had slight elevation in pressure of intra ocular; the mean IOP was 27 mmHg that decrease gradually within eight days.Three patients had post-operative endophthalmitiswhichwell-respond to injections of intravitreal antibiotic (Ceftazedime&vancomycine). Three patients complain regardingocular pain of post-operative which well-respond to panadol extra. Sterile uveitis occurs in two patients that well-responds to topical steroids. One patient was withhemorrhage occurring wherenooccurringas retinal detachment.Generally,itcan be concluded that injection intravitreal (Lucentis) is safe with lowrisks, when we pay a good attention tosurgical procedure, technique and sterilization.